company background image
TCMD

Tactile Systems Technology NasdaqGM:TCMD Stock Report

Last Price

US$7.54

Market Cap

US$151.8m

7D

-8.7%

1Y

-82.8%

Updated

27 Sep, 2022

Data

Company Financials +
TCMD fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

TCMD Stock Overview

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States.

Rewards

Earnings are forecast to grow 105.93% per year

Trading below our calculated fair Price-To-Sales ratio

Risk Analysis

No risks detected for TCMD from our risk checks.

Tactile Systems Technology, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tactile Systems Technology
Historical stock prices
Current Share PriceUS$7.54
52 Week HighUS$46.41
52 Week LowUS$6.28
Beta1.45
1 Month Change-15.09%
3 Month Change-1.31%
1 Year Change-82.77%
3 Year Change-81.78%
5 Year Change-76.36%
Change since IPO-31.95%

Recent News & Updates

Aug 01

Tactile Systems Technology GAAP EPS of -$0.23 misses by $0.09, revenue of $59.6M beats by $2.72M

Tactile Systems Technology press release (NASDAQ:TCMD): Q2 GAAP EPS of -$0.23 misses by $0.09. Revenue of $59.6M (+16.6% Y/Y) beats by $2.72M. Non-GAAP net loss of $2.9 million, compared to non-GAAP net income of $2.0 million in second quarter of 2021. The Company now expects full year 2022 total revenue in the range of $238.0 million to $242.0 million ($237.35M consensus), representing growth of approximately 14% to 16% year-over-year, compared to total revenue of $208.1 million in 2021. The Company’s prior 2022 revenue guidance expectations called for total revenue in the range of $235.0 million to $240.0 million, representing growth of approximately 13% to 15% year-over-year.

Shareholder Returns

TCMDUS Medical EquipmentUS Market
7D-8.7%-7.2%-6.9%
1Y-82.8%-32.3%-23.7%

Return vs Industry: TCMD underperformed the US Medical Equipment industry which returned -32.3% over the past year.

Return vs Market: TCMD underperformed the US Market which returned -23.7% over the past year.

Price Volatility

Is TCMD's price volatile compared to industry and market?
TCMD volatility
TCMD Average Weekly Movement10.0%
Medical Equipment Industry Average Movement8.5%
Market Average Movement6.9%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.8%

Stable Share Price: TCMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: TCMD's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995988Dan Reuvershttps://www.tactilemedical.com

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Tactile Systems Technology, Inc. Fundamentals Summary

How do Tactile Systems Technology's earnings and revenue compare to its market cap?
TCMD fundamental statistics
Market CapUS$151.80m
Earnings (TTM)-US$31.06m
Revenue (TTM)US$221.85m

0.7x

P/S Ratio

-4.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TCMD income statement (TTM)
RevenueUS$221.85m
Cost of RevenueUS$62.99m
Gross ProfitUS$158.86m
Other ExpensesUS$189.92m
Earnings-US$31.06m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 07, 2022

Earnings per share (EPS)-1.54
Gross Margin71.61%
Net Profit Margin-14.00%
Debt/Equity Ratio44.1%

How did TCMD perform over the long term?

See historical performance and comparison